Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Department of Obstetrics and Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
BMC Cancer. 2024 Feb 26;24(1):267. doi: 10.1186/s12885-024-11989-1.
Significant advancements in improving ovarian cancer (OC) outcomes have been limited over the past decade. To predict prognosis and improve outcomes of OC, we plan to develop and validate a robust prognosis signature based on blood features.
We screened age and 33 blood features from 331 OC patients. Using ten machine learning algorithms, 88 combinations were generated, from which one was selected to construct a blood risk score (BRS) according to the highest C-index in the test dataset.
Stepcox (both) and Enet (alpha = 0.7) performed the best in the test dataset with a C-index of 0.711. Meanwhile, the low RBS group possessed observably prolonged survival in this model. Compared to traditional prognostic-related features such as age, stage, grade, and CA125, our combined model had the highest AUC values at 3, 5, and 7 years. According to the results of the model, BRS can provide accurate predictions of OC prognosis. BRS was also capable of identifying various prognostic stratifications in different stages and grades. Importantly, developing the nomogram may improve performance by combining BRS and stage.
This study provides a valuable combined machine-learning model that can be used for predicting the individualized prognosis of OC patients.
在过去十年中,卵巢癌(OC)治疗效果的显著提高受到了限制。为了预测 OC 的预后并改善其治疗效果,我们计划基于血液特征开发和验证一种稳健的预后标志物。
我们筛选了 331 名 OC 患者的年龄和 33 项血液特征。使用十种机器学习算法,生成了 88 种组合,根据测试数据集的最高 C 指数选择其中一种组合构建血液风险评分(BRS)。
Stepcox(两者)和 Enet(alpha = 0.7)在测试数据集中表现最佳,C 指数为 0.711。同时,在该模型中,低 BRS 组的生存时间明显延长。与传统的预后相关特征(如年龄、分期、分级和 CA125)相比,我们的组合模型在 3、5 和 7 年时的 AUC 值最高。根据模型的结果,BRS 可以准确预测 OC 的预后。BRS 还能够识别不同分期和分级中的各种预后分层。重要的是,结合 BRS 和分期构建的列线图可能会提高性能。
本研究提供了一种有价值的联合机器学习模型,可用于预测 OC 患者的个体化预后。